Circulating regulatory T cells in endometrial cancer: a role for age and menopausal status.
AffiliationAcademic Unit of Obstetrics and Gynaecology, School of Cancer and Enabling Sciences, The University of Manchester, Manchester, United Kingdom. email@example.com
MetadataShow full item record
AbstractRegulatory T cells (Treg) are a sub-population of T cells that suppress self-reactivity and are implicated in immune tolerance towards malignant cells. Circulating Treg cells are increased in several cancers. In endometrial cancer Treg cells have been investigated only in tumour tissues and, in contrast to some other tumours, fewer Treg cells were reported in endometrial cancer compared with benign controls. Flow cytometry was used to determine the frequency of circulating Treg cells in women undergoing hysterectomy for either endometrial cancer (n = 24) or non- cancer-related conditions (n = 21). Circulating Treg cells were more abundant in women with cancer compared to those without (4.68% vs. 3.66%, p = 0.05, Mann-Whitney test). This relationship disappeared, however, when only data from post-menopausal women were included in the analysis. Mean Treg cell frequency was 4.65% in postmenopausal women with cancer (n = 23) and 4.73% in postmenopausal controls (n = 5) (p = 0.9). In women without cancer we found that mean Treg cell frequency was higher in postmenopausal women (4.73%, n = 5) in comparison to premenopausal controls (3.33%, n = 16) (p = 0.02). These results suggest that the increased proportion of Treg cells seen in endometrial cancer patients might be, at least in part, attributed to their postmenopausal status or age.
CitationCirculating regulatory T cells in endometrial cancer: a role for age and menopausal status. 2011, 40 (1):62-75 Immunol Invest
- Functional defect of circulating regulatory CD4+ T cells in patients with Wegener's granulomatosis in remission.
- Authors: Abdulahad WH, Stegeman CA, van der Geld YM, Doornbos-van der Meer B, Limburg PC, Kallenberg CG
- Issue date: 2007 Jun
- Homeostasis of peripheral FoxP3(+) CD4 (+) regulatory T cells in patients with early and late stage breast cancer.
- Authors: Rech AJ, Mick R, Kaplan DE, Chang KM, Domchek SM, Vonderheide RH
- Issue date: 2010 Apr
- The effect of menopause on disease activity in systemic lupus erythematosus.
- Authors: Urowitz MB, Ibañez D, Jerome D, Gladman DD
- Issue date: 2006 Nov
- Increase of circulating CD4+CD25highFoxp3+ regulatory T cells in patients with metastatic renal cell carcinoma during treatment with dendritic cell vaccination and low-dose interleukin-2.
- Authors: Berntsen A, Brimnes MK, thor Straten P, Svane IM
- Issue date: 2010 May
- Comparison of endometrial changes among symptomatic tamoxifen-treated and nontreated premenopausal and postmenopausal breast cancer patients.
- Authors: Cheng WF, Lin HH, Torng PL, Huang SC
- Issue date: 1997 Aug